Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19

por Horga, Arantxa, Kuritzkes, Daniel R., Kowalczyk, John J., Pietropaolo, Keith, Belanger, Bruce, Lin, Kai, Perkins, Kristen, Hammond, Janet
Publicado 2023